BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11426970)

  • 1. Prognostic factors of Krukenberg's tumor.
    Kim HK; Heo DS; Bang YJ; Kim NK
    Gynecol Oncol; 2001 Jul; 82(1):105-9. PubMed ID: 11426970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management and outcome of metachronous Krukenberg tumors from gastric cancer.
    Cheong JH; Hyung WJ; Chen J; Kim J; Choi SH; Noh SH
    J Surg Oncol; 2004 Jul; 87(1):39-45. PubMed ID: 15221918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer.
    Cheong JH; Hyung WJ; Chen J; Kim J; Choi SH; Noh SH
    Gynecol Oncol; 2004 Aug; 94(2):477-82. PubMed ID: 15297191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries.
    Kim WY; Kim TJ; Kim SE; Lee JW; Lee JH; Kim BG; Bae DS
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):97-101. PubMed ID: 20018420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical prognostic factors for ovarian metastasis in women with gastric cancer.
    Yook JH; Oh ST; Kim BS
    Hepatogastroenterology; 2007; 54(75):955-9. PubMed ID: 17591102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors.
    Jiang R; Tang J; Cheng X; Zang RY
    Eur J Surg Oncol; 2009 Jan; 35(1):92-7. PubMed ID: 18632244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for ovarian metastasis following curative resection of gastric adenocarcinoma.
    Kim NK; Kim HK; Park BJ; Kim MS; Kim YI; Heo DS; Bang YJ
    Cancer; 1999 Apr; 85(7):1490-9. PubMed ID: 10193938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metastatic carcinoma to the ovary of extragenital origin: analysis of 9 cases and review of the concept of Krukenberg's tumor].
    Hamed F; OyarzĂșn E; Chuaqui R; Wild R; Barrena N; Mayerson D; BadĂ­a JI
    Rev Chil Obstet Ginecol; 1993; 58(3):206-10. PubMed ID: 7991833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological features and prognosis of 68 patients with metastatic ovarian tumors from the gastric cancer].
    Zhao JZ; Wang G; Zhang RP; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):129-32. PubMed ID: 20186624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of advanced gastric cancer surviving 3 years and 6 months after resection of Krukenberg's tumor].
    Ohsako M; Sakoda K; Tabata M; Mizouchi J; Sakamoto H; Yamaguchi A; Misono T; Uchizono H; Yano T; Harada O
    Gan To Kagaku Ryoho; 1994 May; 21(6):873-6. PubMed ID: 8185348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krukenberg's tumor of the ovary: MR imaging features.
    Ha HK; Baek SY; Kim SH; Kim HH; Chung EC; Yeon KM
    AJR Am J Roentgenol; 1995 Jun; 164(6):1435-9. PubMed ID: 7754887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer.
    Cmelak AJ; Kapp DS
    Gynecol Oncol; 1997 Jun; 65(3):453-60. PubMed ID: 9190975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
    Chi DS; Eisenhauer EL; Lang J; Huh J; Haddad L; Abu-Rustum NR; Sonoda Y; Levine DA; Hensley M; Barakat RR
    Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of failures after negative second-look in patients with advanced ovarian cancer: an Italian multicenter study.
    Gadducci A; Sartori E; Maggino T; Zola P; Landoni F; Fanucchi A; Palai N; Alessi C; Ferrero AM; Cosio S; Cristofani R
    Gynecol Oncol; 1998 Feb; 68(2):150-5. PubMed ID: 9514797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krukenberg's tumor in the young population.
    Gupta P; Snebold MA; O'Donnelly S
    J Am Osteopath Assoc; 1989 Apr; 89(4):500-2, 505. PubMed ID: 2544543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?
    Zang RY; Li ZT; Tang J; Cheng X; Cai SM; Zhang ZY; Teng NN
    Cancer; 2004 Mar; 100(6):1152-61. PubMed ID: 15022281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
    Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR
    Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Krukenberg's tumor: still a somber prognosis. 4 cases].
    el Mansouri A; Moumen M; Louahlia A; el Fares F
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):497-500. PubMed ID: 8228013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
    Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
    Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.